Medulloblastoma News and Research

RSS
Stem-like cells found to drive growth of aggressive pediatric brain tumors

Stem-like cells found to drive growth of aggressive pediatric brain tumors

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

Targeting a non-encoding stretch of RNA may shrink pediatric brain tumors in mice

Targeting a non-encoding stretch of RNA may shrink pediatric brain tumors in mice

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Air quality and residential greenness influence childhood cancer development

Air quality and residential greenness influence childhood cancer development

Research potentially expands options for patients with aggressive childhood cancer

Research potentially expands options for patients with aggressive childhood cancer

USC scientists develop first all-human brain organoids model of the cerebellum with functional neurons

USC scientists develop first all-human brain organoids model of the cerebellum with functional neurons

Circular extrachromosomal DNA identified as a potential target for new medulloblastoma therapies

Circular extrachromosomal DNA identified as a potential target for new medulloblastoma therapies

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

Researchers develop new method to find mutations in pediatric brain tumors

Researchers develop new method to find mutations in pediatric brain tumors

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers

Novel immunotherapy appears to be safe, well tolerated by children with relapsed brain tumors

Novel immunotherapy appears to be safe, well tolerated by children with relapsed brain tumors

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

New research pinpoints key culprit behind brain cancer metastasis in children

New research pinpoints key culprit behind brain cancer metastasis in children

New way to carry drugs across the blood-brain barrier using nanoparticles

New way to carry drugs across the blood-brain barrier using nanoparticles

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

Georgia State brain researcher receives NIH grant to create a model for personalized cancer treatments

Georgia State brain researcher receives NIH grant to create a model for personalized cancer treatments

Human fetal cerebellar cell atlas reveals the origin of aggressive medulloblastomas

Human fetal cerebellar cell atlas reveals the origin of aggressive medulloblastomas

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.